These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 94400)
1. A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles. Man RY; Dresel PE J Cardiovasc Pharmacol; 1979; 1(3):329-42. PubMed ID: 94400 [TBL] [Abstract][Full Text] [Related]
2. Effects of lidocaine on conduction of extrasystoles in the normal canine heart. Carson DL; Dresel PE J Cardiovasc Pharmacol; 1981; 3(5):924-35. PubMed ID: 6168860 [TBL] [Abstract][Full Text] [Related]
3. Effect of lidocaine on ventricular conduction in acutely ischemic dog hearts. Carson DL; Dresel PE J Cardiovasc Pharmacol; 1983; 5(3):357-63. PubMed ID: 6191132 [TBL] [Abstract][Full Text] [Related]
4. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles. Hattori Y; Hidaka T; Aisaka K; Satoh F; Ishihara T J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine. Kondo T; Yamaki M; Kubota I; Tachibana H; Tomoike H J Am Coll Cardiol; 1997 Jun; 29(7):1639-44. PubMed ID: 9180130 [TBL] [Abstract][Full Text] [Related]
6. Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart. Duker BG Cardiovasc Res; 1991 Mar; 25(3):217-22. PubMed ID: 1903081 [TBL] [Abstract][Full Text] [Related]
7. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers. Kinnaird AA; Man RY Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981 [TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction. Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198 [TBL] [Abstract][Full Text] [Related]
9. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone. Kreeger RW; Hammill SC Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic properties of a new antiarrhythmic drug--tocainide. Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575 [No Abstract] [Full Text] [Related]
11. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction. Kinnaird AA; Man RY Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761 [TBL] [Abstract][Full Text] [Related]
12. Effect of encainide and its two major metabolites on cardiac conduction. Dresel PE J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542 [TBL] [Abstract][Full Text] [Related]
13. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers. Valois M; Sasyniuk BI Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617 [TBL] [Abstract][Full Text] [Related]
14. Experimental studies on the antiarrhythmic action of a lidocaine analog. Okuma K; Sugiyama S; Wada M; Sugenoya J; Niimi N Cardiology; 1976; 61(4):289-97. PubMed ID: 65226 [TBL] [Abstract][Full Text] [Related]
15. Selective effects of tocainide in canine acute myocardial infarction. Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552 [TBL] [Abstract][Full Text] [Related]
16. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide. Camm AJ Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820 [No Abstract] [Full Text] [Related]
17. Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials: consideration of aim of antiarrhythmic drug therapy. Nakaya Y; Nii H; Nomura M; Fujino K; Mori H Am Heart J; 1989 Nov; 118(5 Pt 1):907-12. PubMed ID: 2479250 [TBL] [Abstract][Full Text] [Related]
18. Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium. Hashimoto H; Satoh N; Nakashima M Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):683-90. PubMed ID: 2096300 [TBL] [Abstract][Full Text] [Related]
19. Effects of calcium antagonists and lidocaine on conduction delay induced by acute myocardial ischemia in dogs. Nakaya H; Hattori Y; Kanno M Jpn J Pharmacol; 1980 Oct; 30(5):587-97. PubMed ID: 7206368 [TBL] [Abstract][Full Text] [Related]
20. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs. Almotrefi AA; Baker JB J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]